- Issuer ticker
-
BLUE
- Reported as of
-
06 Nov 2024
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
08 Nov 2024, 16:08:53 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Sydney Gaylin, Attorney-in-Fact
Key filing fact
Richard A. Paulson filed Form 4 for bluebird bio, Inc. (BLUE) on 08 Nov 2024.
Key facts
- This page summarizes Richard A. Paulson's Form 4 filing for bluebird bio, Inc. (BLUE).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Nov 2024, 16:08.
Change
- Previous filing in this sequence was filed on 06 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLUE
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +24,900
- Change %
- +534%
- Price
-
$0.000000
- Shares after
- 29,563
- Date
- 06 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BLUE
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +49,850
- Change %
- Price
-
$0.000000
- Shares after
- 49,850
- Date
- 06 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 49,850
- Exercise price
- $0.4400
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes